Top-ranked stocks INSP, SIMO, GWRE and ALL are likely to beat on the bottom line in their upcoming releases.
Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Investors interested in Medical Info Systems stocks are likely familiar with Inspire Medical Systems (INSP) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks offers value investors a

New Strong Buy Stocks for March 24th

05:56am, Tuesday, 24'th Mar 2026
STRT, DXPE, ASTE, OPRX and INSP have been added to the Zacks Rank #1 (Strong Buy) List on March 24, 2026.
Inspire Medical Systems, Inc. (INSP) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Bamco Inc. NY decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE: INSP) by 61.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securiti
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
I initiate coverage on Inspire Medical Systems (INSP) with a speculative buy, citing its innovation and leadership in hypoglossal nerve stimulation for obstructive sleep apnea. INSP's depressed 1.6x E
Inspire Medical continues to grow on strong Q4 results and continued R&D investments as the company advances its sleep apnea therapy.
MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minim
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has comme
Inspire Medical Systems, Inc. (NYSE: INSP - Get Free Report) gapped down before the market opened on Friday. The stock had previously closed at $68.05, but opened at $63.02. Inspire Medical Systems sh
NEW YORK and NEW ORLEANS, Feb. 13, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance i
INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE